A B S T R A C T Myeloperoxidase (MPO), a heme enzyme present in the azurophilic granules of human polymorphonuclear neutrophils (PMN), is important in the oxygen-dependent microbicidal activity of PMN. MPO deficiency, defined as the lack of PMN peroxidative activity, is a common genetic defect of human PMN. The purpose of our study was to characterize the structural basis for this loss of enzymatic activity, using protein biochemical and immunochemical techniques to examine PMN from three subjects with partial MPO deficiency and from five subjects with complete MPO deficiency.
lized in SDS and component peptides separated by SDS-PAGE. The peptides were electroblotted onto nitrocellulose paper that was exposed sequentially to rabbit anti-MPO and '251-protein A before autoradiography. Radiolabeled bands were identical when partially purified MPO or normal PMN were compared except that whole PMN contained a small amount of an immunologically cross-reactive membrane associated material of 75,000-90,000 mol wt. Using a modification of this immunoautoradiographic analysis, we quantitated the relative amounts of MPO peptides in PMN. PMN from MPO-deficient subjects contain 41.0-52.3% the amount of MPO peptides present in normal PMN. Similar analysis showed that completely MPO-deficient PMN lacked any peptides corresponding to MPO peptides.
We conclude that partial MPO deficiency is characterized by the presence of electrophoretically and immunologically normal MPO in amounts approximately one-half that seen in PMN from normal subjects. Completely MPO-deficient PMN lack any normal MPO peptides. No MPO-deficient subject studied had an immunologically cross-reacting variant of MPO. Since this deficiency is associated with the absence of more than one peptide, it is possible that the underlying genetic defect may involve: (a) failure to synthesize a single precursor peptide; (b) abnormal regulation of the synthesis of two separate peptides; or (c) an aberration in postsynthetic processing or packaging into azurophilic granules.
INTRODUCTION
Myeloperoxidase (MPO)' is a heme enzyme that comprises 2-4% of the polymorphonuclear leukocyte (PMN) by weight and is present in smaller amounts in monocytes (1) . When stimulated the PMN consumes oxygen and produces superoxide anion, hydrogen peroxide (H202), and other toxic oxygen species. Klebanoff and others first described the enhanced microbicidal activity of H202 and a halide in the presence of MPO (2) (3) (4) (5) . MPO catalyzes the production of hypohalous acids, primarily hypochlorous acid in physiologic situations, and other toxic intermediates that greatly enhance PMN microbicidal activity (6) .
Several studies over the past twenty years have described subjects whose PMN lack MPO activity (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Although MPO deficiency is occasionally an acquired defect associated with another hematologic abnormality (18) (19) (20) (21) , primary MPO deficiency is the form more commonly reported. Until recently primary MPO deficiency appeared to be a rare entity, with only 15 cases in the literature (7) (8) (9) (10) (11) (12) (13) (14) . Recently, using automated flow cytochemistry, we reported the prevalence of primary MPO deficiency to be one in several thousand (16) . Earlier studies suggested that MPO deficiency is an autosomal recessive genetic defect (7-9); however our more recent studies demonstrated that expression of the defect by family members was quite variable and this finding has been supported by other studies (14, 15) .
Although in vitro evidence suggests an important role for MPO in PMN microbicidal activity and recent epidemiologic data indicate that MPO deficiency is relatively common, most people with MPO deficiency are healthy, suffering neither frequent nor severe infections. A few cases of visceral candida infections in subjects with MPO deficiency have been reported (9, 11, 14, 16) , and in vitro studies of microbicidal activity of MPO-deficient PMN have demonstrated a profound defect in candidacidal activity with only a mild impairment of the ability to kill bacteria (9, 11, 15, 16, 22 (24) . Each of the heavy subunits coordinates with an iron-containing heme group giving MPO its characteristic bright green color as a result of its peak light absorbance at a wavelength of 430 nm. In this model the two heavy-light protomers are linked along their long axes by a single disulfide bond between the two heavy subunits. This bond can be broken by reduction producing "hemi-myeloperoxidase." These two halves of myeloperoxidase retain the full specific activity of native MPO, suggesting that peroxidative activity is not primarily dependent upon interaction between the heme groups of the two protomers in the native enzyme.
MPO deficiency has been defined as the lack of MPO peroxidative activity in PMN and monocytes. The complex pattern of inheritance of MPO deficiency, the fact that MPO is composed of at least two distinct peptides, and the requirement of the iron-containing heme group for maximal enzyme activity raised the possibilities that MPO deficiency might represent synthesis of an aberrant enzyme, loss of the heme group from the enzyme, failure to synthesize one of the two MPO peptides, or the complete absence of any MPO peptide. Our earlier observations that MPO-deficient PMN varied in their ability to iodinate protein, a function believed to be mediated by MPO, and that MPOdeficient PMN had residual peroxidase activity when assessed by the oxidation of o-tolidine (16) further supported these possibilities. Salmon et al. (10) used antiserum to MPO in immunofluorescence studies to examine leukocytes from a single subject with MPO deficiency. Neither PMN nor monocytes from that subject appeared to bind the antiserum. However, the presence of small amounts of MPO cannot be excluded by such fluorescence studies.
Our recent identification of many subjects with complete or partial MPO deficiency has allowed us to examine the biochemical nature of the defect in a large group of unrelated subjects. We analyzed the proteins from PMN of five subjects with complete MPO deficiency and three subjects with partial MPO deficiency. Light absorbance at 430 nm, patterns of peptide migration after polyacrylamide gel electrophoresis (PAGE), and results of immunoautoradiographic analysis demonstrated clearly that complete MPO deficiency is associated with the absence of any MPO peptides in the PMN, whereas partial deficiency is associated with the presence of decreased amounts of normal MPO. METHODS Subjects with MPO deficiency. We studied five subjects whose PMN lacked detectable peroxidase activity and three subjects whose PMN had less than normal peroxidase activity. All but one of the individuals studied were among the 29 subjects with MPO deficiency whom we reported earlier (16) . An additional individual presented in this study had complete deficiency of MPO and was identified by Dr. Parry subsequent to publication of the original study. The techniques used to identify subjects with MPO deficiency and the additional studies employed to quantitate enzymatic activitv were outlined in our original report.
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The eight subjects in our present study were unrelated adults 16 Cell preparation. PMN were purified from fresh heparinized venous blood obtained from subjects with MPO deficiency and from normal volunteers. Venous blood was subjected to Ficoll-hypaque density gradient centrifugation followed by 3% dextran sedimentation and hypotonic lysis of erythrocytes, yielding cell preparations that were 90-97% PMN.
The large numbers of normal PMN needed for the preparation of purified MPO were obtained by 3% dextran sedimentation of granulocyte packs prepared for transfusion by batch centrifugation with hydroxyethyl starch (25) and had outdated no >24 h before our procuring them. A typical preparation yielded more than 6 X 109 PMN at >90% purity.
Purification of MPO. PMN isolated as described above were suspended in Hanks' balanced salt solution (HBSS) at 2.5 X 106 PMN/ml and exposed to 1 mM diisopropyl fluorophosphate (DFP) at 00C for 1 h to inhibit the activity of PMN proteases (26) . PMN (28) . Fractions from the G-150 column having the highest A430 also had the highest A430/A280, between 0.75 and 0.79, and the greatest peroxidase activity, measured spectrophotometrically using 4-aminoantipyrine (Sigma Chemical Co.) as the chromogen (see below). Analysis of column fractions by SDS-PAGE showed that those with the highest A430/A280 and peroxidase activity contained primarily MPO peptides and a small amount of a contaminant of -81,000 mol wt.
These fractions with the highest A430/A280 were pooled, Iyophilized, dissolved in 0.2 ml of column buffer and applied to the same Sephadex G-150 column. Fractions were eluted with the same column buffer and the green fractions containing the highest concentration of MPO as determined by A430 measurements had an A430/A280 of 0.80-0.82 and appeared to be pure MPO by SDS-PAGE. This pure material was used as the immunogen in rabbits to raise antiserum against MPO. Because this purification procedure involved substantial loss of MPO between the first and second runs on the Sephadex G150 column, we used the partially pure MPO from the first column in a number of studies in which MPO was needed as a control in enzymatic analyses or where MPO was needed as a marker in PAGE analysis. The 81,000-mol wt peptide lacked peroxidase activity and did not adversely affect the stability of pure MPO. We will refer to this material as "partially purified MPO" and to that material eluted from the second column as "pure MPO."
Preparation of granule protein extracts. MPO-enriched granule protein extracts were prepared from the smaller number of PMN available from normal donors and MPOdeficient subjects using a modification of the procedure used in the purification of MPO from granulocyte transfusions. PMN at 1 to 2 X 108 PMN/ml suspended in 0.34 M sucrose at 0C were homogenized with a Potter-Elvehjem homogenizer (J. T. Baker Co., Phillipsburg, NJ) at 6,000 rpm for several 2-min intervals until cell breakage was estimated at >90% by phase microscopy. The homogenate was centrifuged at 1,800 g for 10 min and the supernate centrifuged at 12,000 g for 30 min to obtain a granule pellet that was stored in liquid nitrogen.
The thawed granules were suspended in 0.02 M K3PO4 (pH 7.4) with 0.5% cetyltrimethylammonium bromide, sonicated, and centrifuged. As described in the previous section the supernate was dialyzed overnight in 0.02 M K3PO4 and the white precipitate that formed was removed by centrifugation. The supernate was further enriched for MPO by differential precipitation with ammonium sulfate [(NH4)2SOG4 using a modification of the technique of Bakkenist (29) . Proteins precipitating at 50% saturation with (NH4)2SO4 were discarded and the precipitate formed between 50%.and 72% (NH4)2SO4 saturation was collected, the pH maintained at 7.3 throughout the precipitation using 1 M K2HPG4. The precipitate was dissolved in 100 mM sodium acetate (pH 4.9) and again subjected to differential salt precipitation. The fraction precipitating between 50 and 65% (NH4)2SO4 was collected, dissolved in a small volume of 100 mM K3PG4 (pH 7.4), and dialyzed overnight in the same buffer at 4°C.
When normal PMN were used as starting material, the initial extract of PMN granules had a specific activity for peroxidase of 10.2 U/mg protein, whereas the final dialysate had a specific activity of 30.7 U/mg protein, suggesting a threefold enrichment in MPO had been obtained. We will refer to this material as "MPO-enriched granule protein extract."
Preparation of antiserum to MPO. Pure MPO was mixed with complete Freund's adjuvant and injected subcutaneously into a New Zealand white rabbit. Repeated injections at 2-wk intervals were continued for 10 wk, at which time serum from the immunized rabbit was found to form a single In other studies whole PMN, granule protein extract, purified MPO, or various protein molecular weight standards were solubilized in SDS solubilizing buffer, heated at 90'C for 2 min, and directly electrophoresed into 0.2% SDS, 10% or 13% polyacrylamide slab gels with stacking gels of 3.5% polyacrylamide (31) . Although PMN solubilized in the SDS solubilizing buffer formed a very viscous solution that was difficult to place into wells in the stacking gel, proteins in the viscous solution appeared to electrophorese normally into the polyacrylamide slab gel.
The molecular weights of MPO or other peptides as described in the results were extrapolated from molecular weight curves determined by SDS-PAGE analysis of a large number of protein standards of known molecular weight. Molecular weights of peptides from 25,000 to 120,000 were determined in 10% polyacrylamide slab gels, where the relationship between the distance migrated into the gel and the molecular weight is linear when plotted semilogarithmically. Molecular weight determination of peptides of 6,000 to 25,000 were obtained on 13 or 15% polyacrylamide slab gels. In some instances we used SDS-PAGE analysis with 10% polyacrylamide gels to achieve better resolution of higher molecular weight peptides. In such 10% gels, the lower molecular weight component of MPO migrated with the dye front where molecular weight determination is not possible. Where a molecular weight is indicated in such an instance, the molecular weight was determined in a higher percent acrylamide gel and no material of lower molecular weight was detected.
Immunoautoradiographic detection of MPO peptides. After separation of PMN proteins by SDS-PAGE, the banding pattern was transferred electrophoretically from the gel to nitrocellulose paper according to the technique of Towbin et al. (32) . A sheet of nitrocellulose paper was placed on one side of the slab gel and this gel and paper placed in the transfer apparatus. The transfer was performed in an apparatus in which electrical current is passed perpendicular to the plane of the gel, thus transferring some of the protein from the gel to the nitrocellulose paper, where the protein adheres electrostatically. The 
The nitrocellulose paper was placed in 50 ml of Burridge buffer (50 mM Tris base, 150 mM NaCI, 0.005% NaN3 at pH 8.7) containing 3% bovine serum albumin (BSA, radioimmunoassay grade, Sigma Chemical Co.) overnight. The paper was then placed in rabbit anti-MPO serum or preimmune rabbit serum (diluted 1:40) in 3% BSA in Burridge buffer for 2 h at room temperature. The paper was extensively washed over 1 h with multiple changes of Burridge buffer and then placed in 50 ml of Burridge buffer containing 3% BSA and '251-protein A (1 to 3 X 105 cpm/ml provided by Dr. V. T. Andriole, Yale University) for 1 h at room temperature. The paper was extensively washed over several hours with multiple changes of Burridge buffer, left overnight in the same buffer, and again washed well the next morning. The paper was dried and autoradiographed using Kodak XAR-5 x-ray film (Eastman Kodak Co., Rochester, NY) and a fluorescence intensifying screen.
Immunochemical quantitation of MPO peptides. We experimentally determined that the electroblot transfer of SDS-PAGE separated peptides from the gel to nitrocellulose paper can be used to quantitate the amount of peptide originally present in the sample loaded on the gel. A range of concentrations of whole PMN from two normal subjects and samples of purified MPO were solubilized in SDS solubilizing buffer and loaded in different lanes of a multilaned 13% polyacrylamide SDS gel. PAGE was performed in the usual fashion and the peptides transferred electrophoretically to nitrocellulose paper as described. After sequential exposure to anti-MPO and 125I-protein A the paper was dried and autoradiographed as described above.
The optical densities of the bands on the autoradiograph are not linearly related to the amount of radioactivity on the paper. Therefore, we instead used the autoradiograph as a guide to cut out the areas of the nitrocellulose paper containing each MPO peptide. Pieces of paper corresponding to the MPO subunit peptides at 59,000-, 39,000-, 24,000-and 13,500-mol wt were cut out. Control pieces of the paper of size equal to a particular band were cut from an adjacent portion of the paper that did not contain any peptides. The pieces of nitrocellulose paper were counted in a gamma counter. We consistently found that for the 59,000-and 39,000-mol wt bands there is a linear relationship between counts and the number of cells in the original sample loaded in the range of 2.5 to 10 X 106 PMN. Using this technique it was also possible to quantitate the amount of MPO in the sample when compared to a similarly run sample of a known amount of purified MPO. Assay of MPO activity. Activity of MPO in the low pH gels, where the enzyme was still in its native state, was determined by the technique of Graham and Karnovsky (33) . Unfixed gels were soaked in 0.5 mM 3,3'-diaminobenzidine tetrahydrochloride (DAB-4HCl, Polysciences, Inc., Warrington, PA) in 35 mM #l-alanine at pH 4.5 followed by exposure to freshly prepared 3.5 mM H202 for 5 min. Gels were fixed in 12.5% trichloroacetic acid for 1 h and stored in 7% acetic acid.
The peroxidative activity of MPO-enriched granule proteins, partially purified MPO, and pure MPO was measured using 4-aminoantipyrine as the chromagen (Sigma Chemical Co.). In a 3-ml cuvette 1.4 ml of 2.5 mM 4-aminoantipyrine in 170 mM phenol was mixed with 1.5 ml of 1.7 mM H202 (prepared fresh daily) and incubated 3-4 min at 250C. An aliquot of 100 Ml of dilute sample was added and the increase in A510 measured for 5 min. A unit of enzymatic activity was defined as the amount of enzyme that catalyzes the decomposition of 1 mmol of H202/min at 250C and pH 7.0 and correlated with a change of 1.0 U of OD/min at 510 nm (34) .
Protein determination. Protein concentrations of samples loaded onto gels were determined by the technique of Sedmak and Grossberg (35) .
RESULTS
Electrophoretic pattern of pure MPO. Pooled fractions of highly purified MPO obtained after separation over the G150 Sephadex column were green in color and had an A430/A280 of 0.81. Fig. 1 a reducing agent (10% f0-mercaptoethanol). Under reducing conditions pure MPO appears to be composed of a 59,000-mol wt peptide, a 13,500-mol wt peptide, which migrates at the dye front in the 10% polyacrylamide gel, and a very small amount of a 39,000-mol wt peptide. Under non-reducing conditions approximately one-half of the 59,000-mol wt peptide electrophoreses with an apparent molecular weight of 39,000. This phenomenon has been noted in some earlier studies and postulated to reflect the presence of an intrapeptide disulfide band that decreases the average radius of the otherwise SDS-denatured peptide (34) .
In other studies pure MPO was electrophoresed under nondenaturing conditions into acidic tube gels as described in Methods. Pure MPO migrates as a broad though apparently single green band located -0.75 of the distance from the origin to the basic fuchsin dye front (not shown). When this gel was fixed and stained with Coomassie Brilliant Blue, a single broad blue band of protein could be seen corresponding to the green band in the unstained gel. This same band also demonstrated peroxidase activity when exposed to H202 and DAB-4HCl (not shown).
An identical acidic tube gel into which nondenatured MPO was electrophoresed was soaked in SDS solubilizing buffer containing 10% ,B-mercaptoethanol for 45 min and placed horizontally atop a 15% polyacrylamide slab gel containing SDS, as described for two-dimensional PAGE analysis in Methods. The peptides of MPO in the tube gel denatured by SDS and reduced by ,B-mercaptoethanol, were electrophoresed into the slab gel producing the pattern seen in Fig. 2 . The single green band of MPO is shown in Fig. 2 to be composed of the 59,000-mol wt peptide and a broad 13,500-mol wt peptide.
Analysis of MPO-enriched granule protein extracts. Granules and MPO-enriched granule protein extracts from the PMN of normal subjects were green and the MPO-enriched granule protein extracts had an A430/A280 of 0.30 to 0.40. Granules and MPOenriched granule protein extracts from equivalent numbers of PMN from partially MPO-deficient subjects were less green than those of normal PMN and the MPO-enriched granule protein extract had an A430/A280 of 0.10 to 0.20. Granules and granule protein extracts from equivalent numbers of PMN from completely MPO-deficient subjects were not green and the granule protein extracts had no light absorption at 430 nm.
Using two-dimensional SDS-PAGE we analyzed the MPO-enriched granule protein extracts from the PMN of several normal subjects and from the PMN Fig. 3 . Fig. 3a shows such an analysis of pure MPO and clearly establishes the location to which the 59,000-mol wt peptide of MPO migrates under the conditions described. We used a 10% acrylamide gel to resolve more clearly the 59,000-mol wt peptide, knowing that we would not clearly identify the 13,500-mol wt peptide that migrates with the dye in this system. In addition, when granule protein extracts are examined in this way (Fig. 3b-d) , the location of the 13,500-mol wt peptide is obscured by other proteins migrating to that area in the second dimension slab gel. By virtue of the analysis used, the 13,500-mol wt peptide can be inferred to be present if the 59,000-mol wt peptide is found at its expected location on the two-dimensional gel.
Two-dimensional PAGE of the MPO-enriched granule extract from normal PMN is shown in Fig. 3b . A prominent 59,000-mol wt peptide is present at the position in this gel identical to that to which the 59,000-mol wt peptide of pure MPO migrated in Fig.   3a . Analysis of similarly processed extracts from the PMN of other normal subjects always resulted in a prominent 59,000-mol wt peptide. However, varying amounts of the unidentified granule proteins were seen with different preparations of MPO-enriched granule extracts. For each of the partially MPO-deficient subjects, analysis of MPO-enriched granule extracts from their PMN resulted in the pattern shown in Fig. 3c . A 59,000-mol wt peptide was always found at the expected position in the gel. Although the intensity of this band relative to the other unidentified peptides in the gel varied among subjects, the 59,000-mol wt peptide band was always less intense than that from normal PMN. Quantitation of the amount of this peptide present in partially MPO-deficient PMN was determined in other studies using an immunochemical analysis (see below).
Granule protein extracts of PMN from each of the five completely MPO-deficient subjects were similarly processed to isolate any normal MPO present and then subjected to the same two-dimensional PAGE. In each case this resulted in a pattern similar to that shown in Fig. 3d . There was a conspicuous absence of the 59,000-mol wt MPO peptide in every case (see arrow in Fig. 3d ), although all of the usually present unidentified peptides were seen.
Immunoautoradiographic detection of MPO peptides in PMN. The above studies suggested that PMN from partially MPO-deficient subjects possess some electrophoretically normal MPO, whereas PMN from completely MPO-deficient subjects do not contain any normal MPO. Using rabbit antiserum directed against MPO, we analyzed PMN from completely MPO-deficient subjects for the presence of any proteins that react with this antiserum. We solubilized partially purified MPO or whole PMN from normal or completely MPO-deficient subjects directly in SDS solubilizing buffer with 10% f-mercaptoethanol and heated the solution to 90'C for 4 min. The sample was electrophoresed into 13% acrylamide SDS slab gels. The separated MPO peptides or PMN proteins were then electroblotted onto nitrocellulose paper as outlined in Methods. The gel was stained in Coomassie Blue and the paper processed, exposed sequentially to the rabbit antiserum to MPO and '251-protein A, and autoradiographed. Fig. 4 shows the results of such analysis, the Coomassie Blue-stained gel in Fig. 4a and the autoradiograph in Fig. 4b .
PMN from several normal donors and from all five completely MPO-deficient subjects were analyzed. The analysis of one normal donor and three of our five completely MPO-deficient subjects is shown in Fig. 4 . Partially purified MPO was electrophoresed into lane 1 of the gel shown in Fig. 4 in place of pure MPO because it contains not only purification, which yields electrophoretically pure MPO but also an 81,000-mol wt contaminant. This MPO. Despite our use of pure MPO as our immunogen, 81,000-mol wt peptide represents the major impurity it was possible that our rabbit antiserum might bind in our preparation of MPO prior to the final column to this contaminant. As shown in Fig. 4 The diffuse faint binding of antibodies in our rabbit antiserum to material at 75,000 to 90,000-mol wt is present in normal and completely MPO-deficient PMN, despite the total absence of normal MPO peptides from the latter. The 75,000-90,000-mol wt material is never seen in the soluble fraction of sonicated PMN granules and is enriched in partially purified membrane fractions of disrupted PMN, suggesting that this material may be membrane associated. To clarify the relationship of this material to MPO, we added increasing amounts of pure MPO to the anti-MPO used to process an electroblot of an SDS PAGE of whole PMN. As increasing amounts of pure MPO were used to block the binding of anti-MPO to the electroblots, the resultant autoradiographs showed a decrease in binding to both the 59,000-mol wt MPO peptide and the 75,000-90,000-mol wt material.
Whole PMN from three different subjects with complete MPO deficiency were solubilized in SDS solubilizing buffer and electrophoresed into lanes 2, 3, and 4 of the gel shown in Fig. 4 . Although there is no obvious difference between normal and completely MPO-deficient PMN in the pattern seen in the gel stained with Coomassie Blue, the corresponding autoradiograph clearly demonstrates that completely MPO-deficient PMN have no material that binds anti-MPO at the molecular weight of known MPO peptides peptides that labeled with anti-MPO (panel b, lanes 2-4) except for material between 75,000 and 90,000 mol wt, which is cross-reactive material seen in normal PMN as well. nor do they have any bands not present in normal PMN. They do, however, contain the 75,000-90,000-mol wt material seen in normal PMN.
Immunoautoradiographic quantitation of MPO in MPO-deficient PMN. To measure immunochemically the amount of MPO present in partially and totally MPO-deficient PMN, we adapted the technique of electroblotting. PMN were isolated from two normal subjects (H.M. and W.N.), three partially MPO-deficient subjects (C.N., C.W., J.G.), and one totally MPOdeficient subject (L.H.). Samples of 5 X 10' PMN from each were subjected to SDS-PAGE and transferred to nitrocellulose paper, which was sequentially exposed to anti-MPO and '251-protein A as described earlier.
The autoradiograph obtained was used to define those areas of the nitrocellulose paper to which the 59,000-mol wt subunit of MPO was bound.
Data from this analysis are presented in Table I 
DISCUSSION
From our studies of PMN from five unrelated subjects with complete MPO deficiency we conclude that complete MPO deficiency, as defined as the absence of peroxidase activity, is a result of the lack of MPO peptides in PMN. PMN from three subjects with partial MPO deficiency contain electrophoretically normal MPO but in approximately one-half the normal amount, compatible with the decreased level of MPO enzymatic activity in the PMN of these subjects. We find no evidence for the presence of abnormal MPO peptides in the PMN of subjects with either complete or partial MPO deficiency.
Our studies demonstrate that pure MPO is composed of peptide subunits of 59,000-and 13,500-mol wt, in agreement with some previous reports (24, (36) (37) (38) . We also clearly show that some of the 59,000-mol wt peptide migrates with an apparent molecular weight of 39,000 in SDS-PAGE under nonreducing conditions.
The nature of the 75,000-90,000-mol wt immunologically cross-reacting peptide found in normal and MPO-deficient PMN and its relationship to the peptides seen in purified MPO are not clear. The competition binding studies show that purified MPO (which itself does not contain any detectable 75,000-90,000-mol wt material) will bind all of the antibodies in the antiserum that cross-react with 75,000-90,000-mol wt material. Preliminary evidence suggests that this material is associated with PMN membranes. Whether this material is a non-MPO peptide antigenically related to MPO or whether this represents an MPO precursor cannot be addressed at this time.
Hypotheses explaining the nature of the genetic lesion underlying MPO deficiency must account for the absence of more than one subunit peptide. Certainly our previous family studies (16) suggest that the mode of inheritance is more complicated than a simple autosomal recessive trait. It is possible that MPO deficiency is an example of a regulatory gene defect manifested by the failure of any MPO peptides to be produced, in contrast to the production of aberrant MPO due to a structural gene defect. Alternatively, it is possible that only one of the peptides of MPO is not synthesized and that the remaining peptide(s) is lost from myeloid precursors during subsequent differentiation in bone marrow. Thirdly, it is possible that MPO 
